# MapLight Therapeutics, Inc. (MPLT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from MapLight Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/MPLT/mda/fy2025/): filed 2026-03-26; accession 0001193125-26-125072 (https://www.sec.gov/Archives/edgar/data/1770069/000119312526125072/mplt-20251231.htm); latest 10-K

Back to /company/MPLT/